Aura Biosciences, Inc. Common Stock

Go to Aura Biosciences, Inc. Common Stock Website

$6.63

0.02 (0.30%)
Live
Previous Close

$6.61

Day Range

$6.48 - $7.02

Previous Day Range

$6.51 - $6.92

Market Cap

$417.9 million USD

Day Vol.

163728

Previous Day Vol.

178549

Currency

USD

Primary Exchange

Nasdaq

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical de...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Aura Biosciences announced the pricing of a public offering of common stock and warrants, raising $75 million. The company plans to use the proceeds to advance its clinical programs in various cancer indications.

Related tickers: AURA.

Read Full Article

Aura Biosciences, a clinical-stage biotechnology company, announced the appointment of Teresa Bitetti, President of the Global Oncology Business Unit at Takeda, to its Board of Directors. Bitetti's extensive operational and commercial experience will be valuable as Aura advances its clinical pipeline in ocular and urologic oncology.

Related tickers: AURA, TAK.

Read Full Article
Trending Tickers

Please sign in to view